TickerFacts.

NovoCure Ltd (NVCR): Operating Cash Flow

Annual figures by period end, from SEC filings.

-$49.03M
Year ended 2025-12-31
-$2.81M
Trailing 12 months to 2026-06-30
$99.15M2013-12-31: -$52.72M2014-12-31: -$74.24M2015-12-31: -$99.88M2016-12-31: -$107.59M2017-12-31: -$33.13M2018-12-31: -$1.86M2019-12-31: $26.62M2020-12-31: $99.15M2021-12-31: $82.76M2022-12-31: $30.79M2023-12-31: -$73.34M2024-12-31: -$26.37M2025-12-31: -$49.03M-$49.03M
2013-12-31 Operating Cash Flow (USD) 2025-12-31
Period endedOperating Cash FlowChange YoYSource filing
2025-12-31-$49.03Mn/m2026-02-26, From 2025-01-01
2024-12-31-$26.37Mn/m2026-02-26, From 2024-01-01
2023-12-31-$73.34Mn/m2026-02-26, From 2023-01-01
2022-12-31$30.79M-62.8%2025-02-27, From 2022-01-01
2021-12-31$82.76M-16.5%2024-02-22, From 2021-01-01
2020-12-31$99.15M+272.5%2023-02-23, From 2020-01-01
2019-12-31$26.62Mn/m2022-02-24, From 2019-01-01
2018-12-31-$1.86Mn/m2021-02-25, From 2018-01-01
2017-12-31-$33.13Mn/m2020-02-27, From 2017-01-01
2016-12-31-$107.59Mn/m2019-02-28, From 2016-01-01
2015-12-31-$99.88Mn/m2018-02-22, From 2015-01-01
2014-12-31-$74.24Mn/m2017-02-23, From 2014-01-01
2013-12-31-$52.72Mn/a2016-03-01, From 2013-01-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
NovoCure Ltd (NVCR)2025-12-31-$49.03Mn/m
UFP Technologies Inc (UFPT)2025-12-31$91.91M+38.0%
iRhythm Holdings, Inc. (IRTC)2025-12-31$80.86Mn/m
Bioventus Inc. (BVS)2025-12-31$74.67M+92.5%
Alphatec Holdings, Inc. (ATEC)2025-12-31$45.23Mn/m
AtriCure, Inc. (ATRC)2025-12-31$57.33M+369.8%
Orthofix Medical Inc. (OFIX)2025-12-31$33.35M+29.3%
Glaukos Corp (GKOS)2025-12-31-$14.79Mn/m
Inspire Medical Systems, Inc. (INSP)2025-12-31$116.98M-10.2%

Compare NVCR, UFPT, IRTC, BVS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗